Navigation Links
Delcath Systems to Host Quarterly Update Conference Call
Date:12/30/2008

NEW YORK, Dec. 30 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH) announced today that the Company will host its quarterly update conference call at 4:30 PM Eastern Time on Thursday, January 22, 2009. Richard Taney, President and Chief Executive Officer of Delcath Systems, will host the call. Mr. Taney will discuss the progress of patient enrollment and the advancement of clinical studies. A question and answer session will immediately follow management's prepared remarks.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081118/NY46990LOGO)

Joining Mr. Taney on the call will be Mark Morrison, MD, PhD, Chief Medical Officer; Jonathan Foltz, Executive Vice President; John Talarico, Senior Vice President Regulatory Affairs and Quality Systems; and Jason Rifkin, Senior Vice President Clinical Operations. Mr. Taney will also introduce Barbra Keck, Delcath's recently hired Controller. Ms. Keck will assume the responsibilities of Principal Accounting Officer following the previously announced departure of Delcath's Chief Financial Officer.

Mr. Taney commented, "2008 was a transformational year for Delcath. We expanded our pivotal Phase III FDA trial from our base at the National Cancer Institute to 10 regionally diversified leading cancer hospitals and passed the important milestone of 50% of patient enrollment. We have also conserved cash resources and assembled a first class executive team and Board of Directors to execute on our clinical and financial milestones as we prepare for commercialization. I look forward to speaking with the investment community in a few weeks to share our excitement for 2009."

The call will be available live and archived via the Delcath website. In addition, the call can be accessed via telephone; dial-in information will be provided a few days prior to the call.

About Delcath Systems, Inc.

Delcath Systems, Inc. is a medical technology company specializing in cancer treatment. The Company is testing a proprietary, patented drug delivery system for the treatment of liver cancers. Delcath's novel drug delivery platform is testing the delivery of ultra-high doses of anti-cancer drugs to the liver while preventing these high doses of drug from entering the patient's bloodstream. The Company is currently enrolling patients in Phase III and Phase II clinical studies for the treatment of liver cancers using high doses of melphalan. The Company's intellectual property portfolio consists of twenty-eight patents on a worldwide basis including the U.S., Europe, Asia and Canada. For more information, please visit the Company's website at www.delcath.com.

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by the Company or on its behalf. This news release contains forward-looking statements, which are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to, uncertainties relating to our ability to successfully complete Phase III clinical trials and secure regulatory approval of our current or future drug-delivery system and uncertainties regarding our ability to obtain financial and other resources for any research, development and commercialization activities. These factors, and others, are discussed from time to time in our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update or revise these forward-looking statements to reflect events or circumstances after the date they are made.


'/>"/>
SOURCE Delcath Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Lutheran Senior Services Partners with Silverchair Learning Systems to Enhance Employee Training and Education
2. Heartline(R) Fitness Systems Named to Inc. Magazines Inaugural List of the 5000 Fastest Growing Private Companies in U.S....
3. Plexus Systems Ranks in Top Third of the 2007 Inc. 5,000 with Three-Year Sales Growth of 226%
4. Document Security Systems (Amex: DMC) Invites You to a Landmark Event
5. Flu Vaccinations Begin on September 29 Maxim Health Systems to Provide 24,000 Flu Shot Clinics Nationwide
6. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
7. Arbios Systems, Incs Q2/07 Analyst Review Issued by Scimitar Equity Research, Inc.
8. CAS Medical Systems, Inc. Awarded $2.8 Million Grant by National Institutes of Health
9. Jon R. Wampler Joins Portico Systems Board of Directors
10. Portico Systems to Share Provider Network Management Best Practices at Institute for International Research
11. Portico Systems Wins Three Awards in 30 Days
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees ... which come courtesy of leaders in the nursing and health care industry. It also ... and associations—namely Abilene Christian University. , As the nursing industry is coming out ...
(Date:5/26/2016)... ... ... Despite last week’s media reports hinting at a June rate hike after the Federal ... an interest rate increase, according to Rajeev Dhawan of the Economic Forecasting Center at ... Committee (FOMC) dot charts are of interest to the press for their noise potential,” ...
(Date:5/26/2016)... California (PRWEB) , ... May 26, 2016 , ... ... associated with discovery of thousands of defective respirators, according to court documents and ... the case of William and Becky Tyler v. American Optical Corporation, Case No. ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, through its ... partner for the Tamika Catchings Legacy Tour that will commemorate the Indiana ... hardwood basketball surfaces in all forms and levels of the game, Connor Sports has ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... India , May 25, 2016 ... Animation Market by Type (3D, 2D, 4D), by Therapeutic ... Education), by End User (Medical Device Manufacturers, Hospitals/ Clinics) ... studies the global Medical Animation Market for the forecast ... to reach USD 301.3 Million by 2021 from USD ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May ... QGEN ; Frankfurt Prime Standard: QIA) today announced that ... with Therawis Diagnostics GmbH to develop and commercialize predictive assays ... market PITX2 as a marker to predict effectiveness of anthracycline ... "We are pleased to partner with Therawis, which ...
(Date:5/25/2016)... -- According to Kalorama Information, the world market for ... these are challenging times in the market, there ... companies that remain optimistic and seek innovation.  Toward ... medical device companies spend a higher percentage of ... do companies in other industries.  Also, in addition ...
Breaking Medicine Technology: